<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00540000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P55210</UniProt_ID>
  <Seq_Length>303</Seq_Length>
  <Molecule_Weight>34277</Molecule_Weight>
  <KEGG_ID>hsa:840</KEGG_ID>
  <Orthology_ID>K04397</Orthology_ID>
  <EBI_ID>EBI-523958</EBI_ID>
  <Function_Summary>Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves and activates sterol regulatory element binding proteins (SREBPs). Proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' bond. Overexpression promotes programmed cell death.</Function_Summary>
  <Catalytic_Mechanism>Strict requirement for an Asp residue at position P1 and has a preferred cleavage sequence of Asp-Glu-Val-Asp-|-.</Catalytic_Mechanism>
  <Pfam_ID>PF00656:Peptidase_C14</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>8</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CASP-7</Alias>
      <Alias>Apoptotic protease Mch-3</Alias>
      <Alias>ICE-LAP3</Alias>
      <Alias>ICE-like apoptotic protease 3</Alias>
      <Alias>CMH-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008234</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004197</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>255</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>4</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process induced by intracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by intracellular signals</Keyword>
      <Ontology_ID>GO:0008629</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The breakdown of structures such as organelles, proteins, or other macromolecular structures during apoptosis.</Detail>
      <Keyword>Cellular component disassembly involved in apoptosis</Keyword>
      <Ontology_ID>GO:0006921</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Upregulation of the activity of a caspase, any of a group of cysteine proteases involved in apoptosis, mediated by cytochrome c.</Detail>
      <Keyword>Activation of caspase activity by cytochrome c</Keyword>
      <Ontology_ID>GO:0008635</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>16</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ</Protein_Seq>
    <DNA_Seq>GAGAGACTGTGCCAGTCCCAGCCGCCCTACCGCCGTGGGAACGATGGCAGATGATCAGGGCTGTATTGAAGAGCAGGGGGTTGAGGATTCAGCAAATGAAGATTCAGTGGATGCTAAGCCAGACCGGTCCTCGTTTGTACCGTCCCTCTTCAGTAAGAAGAAGAAAAATGTCACCATGCGATCCATCAAGACCACCCGGGACCGAGTGCCTACATATCAGTACAACATGAATTTTGAAAAGCTGGGCAAATGCATCATAATAAACAACAAGAACTTTGATAAAGTGACAGGTATGGGCGTTCGAAACGGAACAGACAAAGATGCCGAGGCGCTCTTCAAGTGCTTCCGAAGCCTGGGTTTTGACGTGATTGTCTATAATGACTGCTCTTGTGCCAAGATGCAAGATCTGCTTAAAAAAGCTTCTGAAGAGGACCATACAAATGCCGCCTGCTTCGCCTGCATCCTCTTAAGCCATGGAGAAGAAAATGTAATTTATGGGAAAGATGGTGTCACACCAATAAAGGATTTGACAGCCCACTTTAGGGGGGATAGATGCAAAACCCTTTTAGAGAAACCCAAACTCTTCTTCATTCAGGCTTGCCGAGGGACCGAGCTTGATGATGGCATCCAGGCCGACTCGGGGCCCATCAATGACACAGATGCTAATCCTCGATACAAGATCCCAGTGGAAGCTGACTTCCTCTTCGCCTATTCCACGGTTCCAGGCTATTACTCGTGGAGGAGCCCAGGAAGAGGCTCCTGGTTTGTGCAAGCCCTCTGCTCCATCCTGGAGGAGCACGGAAAAGACCTGGAAATCATGCAGATCCTCACCAGGGTGAATGACAGAGTTGCCAGGCACTTTGAGTCTCAGTCTGATGACCCACACTTCCATGAGAAGAAGCAGATCCCCTGTGTGGTCTCCATGCTCACCAAGGAACTCTACTTCAGTCAATAGCCATATCAGGGGTACATTCTAGCTGAGAAGCAATGGGTCACTCATTAATGAATCACATTTTTTTATGCTCTTGAAATATTCAGAAATTCTCCAGGATTTTAATTTCAGGAAAATGTATTGATTCAACAGGGAAGAAACTTTCTGGTGCTGTCTTTTGTTCTCTGAATTTTCAGAGACTTTTTTATAATGTTATTCATTTGGTGACTGTGTAACTTTCTCTTAAGATTAATTTTCTCTTTGTATGTCTGTTACCTTGTTAATAGACTTAATACATGCAACAGAAGTGACTTCTGGAGAAAGCTCATGGCTGTGTCCACTGCAATTGGTGGTAACAGTGGTAGAGTCATGTTTGCACTTGGCAAAAAGAATCCCAATGTTTGACAAAACACAGCCAAGGGGATATTTACTGCTCTTTATTGCAGAATGTGGGTATTGAGTGTGATTTGAATGATTTTTCATTGGCTTAGGGCAGATTTTCATGCAAAAGTTCTCATATGAGTTAGAGGAGAAAAAGCTTAATGATTCTGATATGTATCCATCAGGATCCAGTCTGGAAAACAGAAACCATTCTAGGTGTTTCAACAGAGGGAGTTTAATACAGGAAATTGACTTACATAGATGATAAAAGAGAAGCCAAACAGCAAGAAGCTGTTACCACACCCAGGGCTATGAGGATAATGGGAAGAGGTTTGGTTTCCTGTGTCCAGTAGTGGGATCATCCAGAGGAGCTGGAACCATGGTGGGGGCTGCCTAGTGGGAGTTAGGACCACCAATGGATTGTGGAAAATGGAGCCATGACAAGAACAAAGCCACTGACTGAGATGGAGTGAGCTGAGACAGATAAGAGAATACCTTGTCTCACCTATCCTGCCCTCACATCTTCCACCAGCACCTTACTGCCCAGGCCTATCTGGAAGCCACCTCACCAAGGACCTTGGAAGAGCAAGGGACAGTGAGGCAGGAGAAGAACAAGAAATGGATGTAAGCCTGGCCCATAATGTGAACATAAGTAATCACTAATGCTCAACAATTTATCCATTCAATCATTTATTCATTGGGTTGTCAGATAGTCTATGTATGTGTAAAACAATCTGTTTTGGCTTTATGTGCAAAATCTGTTATAGCTTTAAAATATATCTGGAACTTTTTAGATTATTCCAAGCCTTATTTTGAGTAAATATTTGTTACTTTTAGTTCTATAAGTGAGGAAGAGTTTATGGCAAAGATTTTTGGCACTTTGTTTTCAAGATGGTGTTATCTTTTGAATTCTTGATAAATGACTGTTTTTTTCTGCCTAATAGTAACTGGTTAAAAAACAAATGTTCATATTTATTGATTAAAAATGTGGTTGCTT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Heart</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Kidney</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Skeletal muscle</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lung</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CASP7</Gene_Name>
    <Gene_Alias>MCH3</Gene_Alias>
    <Gene_ID>840</Gene_ID>
    <Genbank_ACCN>NM_001227</Genbank_ACCN>
    <Protein_ACCN>NP_001218</Protein_ACCN>
    <HGNC_ID>1508</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/840</Gene_URL>
    <UCSC_ID>uc001lao.3</UCSC_ID>
    <EMBL_ID>ENSG00000165806</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q13490</Uniprot_ID>
      <Gene_Name>BIRC2</Gene_Name>
      <EBI_ID>EBI-514538</EBI_ID>
      <PPI_EBI_URL>EBI-523958,EBI-514538</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13177</Uniprot_ID>
      <Gene_Name>PAK2</Gene_Name>
      <EBI_ID>EBI-1045887</EBI_ID>
      <PPI_EBI_URL>EBI-523958,EBI-1045887</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P98170</Uniprot_ID>
      <Gene_Name>XIAP</Gene_Name>
      <EBI_ID>EBI-517127</EBI_ID>
      <PPI_EBI_URL>EBI-523958,EBI-517127</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=CASP7#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastrointestinal Lymphoma</Disease_Name>
      <Disease_Detail>Gastrointestinal Carcinoma</Disease_Detail>
      <Disease_DB>GST014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastrointestinal_lymphoma?search=CASP7#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP</PDB_Title>
      <PDB_ID>1I51</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1I51</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of caspase-7 inhibition by XIAP.</PubMed_Title>
      <Author>Chai J, et al.</Author>
      <Journal>Cell. 2001 Mar 9;104(5):769-80.</Journal>
      <PubMed_ID>11257230</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex</PDB_Title>
      <PDB_ID>1KMC</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KMC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex</PubMed_Title>
      <Author>Riedl SJ, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX</PDB_Title>
      <PDB_ID>1I4O</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1I4O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.</PubMed_Title>
      <Author>Huang Y, et al.</Author>
      <Journal>Cell. 2001 Mar 9;104(5):781-90.</Journal>
      <PubMed_ID>11257231</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7</PDB_Title>
      <PDB_ID>1GQF</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GQF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the activation of human procaspase-7.</PubMed_Title>
      <Author>Riedl SJ, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14790-5.</Journal>
      <PubMed_ID>11752425</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO</PDB_Title>
      <PDB_ID>1F1J</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1F1J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.</PubMed_Title>
      <Author>Wei Y, et al.</Author>
      <Journal>Chem Biol. 2000 Jun;7(6):423-32.</Journal>
      <PubMed_ID>10873833</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of CASPASE-7 in Complex with allosteric inhibitor</PDB_Title>
      <PDB_ID>4FEA</PDB_ID>
      <Resolution>3.79</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FEA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00540004</ASD_Ligand>
      <PubMed_Title>A class of allosteric caspase inhibitors identified by high-throughput screening.</PubMed_Title>
      <Author>Feldman, T., et al.</Author>
      <Journal>Mol.Cell(2012)47:585-595</Journal>
      <PubMed_ID>22795132</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Caspase-7 incomplex with Acetyl-YVAD-CHO</PDB_Title>
      <PDB_ID>3IBC</PDB_ID>
      <Resolution>2.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IBC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>Apoptosis. 2009 Oct;14(10):1135-44.</Journal>
      <PubMed_ID>19655253</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Caspase-7 with inhibitor AC-DNLD-CHO</PDB_Title>
      <PDB_ID>2QLF</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QLF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>FEBS J. 2007 Sep;274(18):4752-65.</Journal>
      <PubMed_ID>17697120</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Caspase-7 in complex with DICA allosteric inhibitor</PDB_Title>
      <PDB_ID>1SHJ</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SHJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00530002</ASD_Ligand>
      <PubMed_Title>Discovery of an allosteric site in the caspases.</PubMed_Title>
      <Author>Hardy JA, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12461-6.</Journal>
      <PubMed_ID>15314233</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Caspase-7 with Inhibitor AC-WEHD-CHO</PDB_Title>
      <PDB_ID>2QLJ</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QLJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00360007</ASD_Ligand>
      <PubMed_Title>Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>FEBS J. 2007 Sep;274(18):4752-65.</Journal>
      <PubMed_ID>17697120</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of caspase-7 with inhibitor AC-DMQD-CHO</PDB_Title>
      <PDB_ID>2QL5</PDB_ID>
      <Resolution>2.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QL5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>FEBS J. 2007 Sep;274(18):4752-65.</Journal>
      <PubMed_ID>17697120</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The crystal structure of caspase-7 in complex with Acetyl-LDESD-CHO</PDB_Title>
      <PDB_ID>3EDR</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EDR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for executioner caspase recognition of P5 position in substrates.</PubMed_Title>
      <Author>Fu G, et al.</Author>
      <Journal>Apoptosis. 2008 Nov;13(11):1291-302.</Journal>
      <PubMed_ID>18780184</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR</PDB_Title>
      <PDB_ID>1SHL</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SHL</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00530001</ASD_Ligand>
      <PubMed_Title>Discovery of an allosteric site in the caspases.</PubMed_Title>
      <Author>Hardy JA, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12461-6.</Journal>
      <PubMed_ID>15314233</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Mature Caspase-7 I213A with DEVD-CHO inhibitor bound to active site</PDB_Title>
      <PDB_ID>3H1P</PDB_ID>
      <Resolution>2.61</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H1P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>L2' loop is critical for caspase-7 active site formation.</PubMed_Title>
      <Author>Witkowski WA, et al.</Author>
      <Journal>Protein Sci. 2009 Jul;18(7):1459-68.</Journal>
      <PubMed_ID>19530232</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of procaspase-7</PDB_Title>
      <PDB_ID>1K88</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K88</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.</PubMed_Title>
      <Author>Chai J, et al.</Author>
      <Journal>Cell. 2001 Nov 2;107(3):399-407.</Journal>
      <PubMed_ID>11701129</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Caspase-7 with inhibitor AC-IEPD-CHO</PDB_Title>
      <PDB_ID>2QL7</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QL7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>FEBS J. 2007 Sep;274(18):4752-65.</Journal>
      <PubMed_ID>17697120</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of caspase-7</PDB_Title>
      <PDB_ID>1K86</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K86</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.</PubMed_Title>
      <Author>Chai J, et al.</Author>
      <Journal>Cell. 2001 Nov 2;107(3):399-407.</Journal>
      <PubMed_ID>11701129</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Caspase-7 with inhibitor AC-DQMD-CHO</PDB_Title>
      <PDB_ID>2QL9</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QL9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>FEBS J. 2007 Sep;274(18):4752-65.</Journal>
      <PubMed_ID>17697120</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of unliganded caspase-7</PDB_Title>
      <PDB_ID>3IBF</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IBF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>Apoptosis. 2009 Oct;14(10):1135-44.</Journal>
      <PubMed_ID>19655253</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of caspase-7 with inhibitor AC-ESMD-CHO</PDB_Title>
      <PDB_ID>2QLB</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QLB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.</PubMed_Title>
      <Author>Agniswamy J, et al.</Author>
      <Journal>FEBS J. 2007 Sep;274(18):4752-65.</Journal>
      <PubMed_ID>17697120</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05134</Pathway_ID>
      <Pathway_Title>Legionellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04210</Pathway_ID>
      <Pathway_Title>Apoptosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04668</Pathway_ID>
      <Pathway_Title>TNF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04932</Pathway_ID>
      <Pathway_Title>Non-alcoholic fatty liver disease (NAFLD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05010</Pathway_ID>
      <Pathway_Title>Alzheimer's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.id.b.b.f.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1shj</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,290,Cys;site,223,Tyr;site,187,Arg</Site_Detail>
      <Site_Reference>Hardy J A, et al. Proc Natl Acad. 2004,101(34):12461-12466.</Site_Reference>
      <Site_Type>Open-Close</Site_Type>
      <PDB_ID>1SHJ;1SHL</PDB_ID>
      <PubMed_ID>15314233</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.22.60</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/22/60.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00360007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00520002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00520003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00520004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00520005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00530001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00530002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00540004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>